MedPage Today | Rheuminations: 2013 Year in Review MedPage Today However, by the end of 2013 we now have many comparator trials that show after failing an initial TNF inhibitor, there is equivalent or better efficacy when targeting different mechanisms with abatacept, rituximab or tocilizumab, compared with using ... |
